The antibiotic resistome: The nexus of chemical and genetic diversity

Nature Reviews Microbiology

Volumn 5, Issue 3, 2007, Pages 175-186

  Wright, Gerard D ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOGLYCOSIDE KINASE; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CHLORTETRACYCLINE; DAPTOMYCIN; ERYTHROMYCIN; GRAMICIDIN; LINEZOLID; NALIDIXIC ACID; NEOMYCIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PENICILLIN DERIVATIVE; PENICILLIN G; PHOSPHOTRANSFERASE; POLYMYXIN; RIFAMYCIN; STREPTOGRAMIN; STREPTOMYCIN; TRANSPOSASE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL GENOME; BACTERIAL MEMBRANE; BACTERIAL METABOLISM; BACTERIAL VIRULENCE; DNA TRANSFER; DRUG HYDROLYSIS; DRUG PROTEIN BINDING; DRUG RESEARCH; DRUG TREATMENT FAILURE; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR EVOLUTION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ANTI-BACTERIAL AGENTS; BACTERIA; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EVOLUTION, MOLECULAR; GENE TRANSFER, HORIZONTAL; HUMANS; INTERSPERSED REPETITIVE SEQUENCES; VARIATION (GENETICS);

BACTERIA (MICROORGANISMS);

EID: 33847151750     PISSN: 17401526     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrmicro1614     Document Type: Review

References (99)

1. Winau, F., Westphal, O. & Winau, R. Paul Ehrlich - in search of the magic bullet. Microbes Infect. 6, 786-789 (2004).
2. Overbye, K. M. & Barrett, J. F. Antibiotics: Where did we go wrong? Drug Discov. Today 10, 45-52 (2005).
3. Projan, S. J. Why is big Pharma getting out of antibacterial drug discovery? Curr. Opin. Microbiol. 6, 427-430 (2003).
4. Projan, S. J. & Shlaes, D. M. Antibacterial drug discovery: Is it all downhill from here? Clin. Microbiol. Infect. 10 (Suppl. 4), 18-22 (2004).
5. Tenover, F. C. Mechanisms of antimicrobial resistance in bacteria. Am. J. Med. 119, S3-S10; discussion S62-S70 (2006).
6. McGowan, J. E. Jr. Resistance in nonfermenting Gram-negative bacteria: multidrug resistance to the maximum. Am. J. Infect. Control 34, S29-S37; discussion S64-S73 (2006).
7. Giamarellos-Bourboulis, E. J. et al. Clarithromycin is an effective immunomodulator in experimental pyelonephritis caused by pan-resistant Klebsiella pneumoniae. J. Antimicrob. Chemother. 57, 937-944 (2006).
8. Levy, S. B. & Marshall, B. Antibacterial resistance worldwide: Causes, challenges and responses. Nature Med. 10, S122-S129 (2004).
9. Livermore, D. M. The need for new antibiotics. Clin. Microbiol. Infect. 10 (Suppl. 4), 1-9 (2004).
10. Alekshun, M. N. & Levy, S. B. Commensals upon us. Biochem. Pharmacol. 71, 893-900 (2006).
11. Rice, L. B. Unmet medical needs in antibacterial therapy. Biochem. Pharmacol. 71, 991-995 (2006).
12. Robinson, D. A. et al. Re-emergence of early pandemic Staphylococcus aureus as a community-acquired methicillin-resistant clone. Lancet 365, 1256-1258 (2005).
13. File, T. M. Jr. Clinical implications and treatment of multiresistant Streptococcus pneumoniae pneumonia. Clin. Microbiol. Infect. 12 (Suppl. 3), 31-41 (2006).
14. Nguyen, L. & Thompson, C. J. Foundations of antibiotic resistance in bacterial physiology: The mycobacterial paradigm. Trends Microbiol. 14, 304-312 (2006).
15. Riley, M. et al. Escherichia coli K- 12: A cooperatively developed annotation snapshot - 2005. Nucleic Acids Res. 34, 1-9 (2006).
16. Yu, E. W., McDermott, G., Zgurskaya, H. I., Nikaido, H. & Koshland, D. E. Jr. Structural basis of multiple drug-binding capacity of the AcrB multidrug efflux pump. Science 300, 976-980 (2003).
17. Hillen, W. & Berens, C. Mechanisms underlying expression of Tn 10 encoded tetracycline resistance. Annu. Rev. Microbiol. 48, 345-369 (1994).
18. Ramos, J. L. et al. The TetR family of transcriptional repressors. Microbiol. Mol. Biol. Rev. 69, 326-356 (2005).
19. Alekshun, M. N. & Levy, S. B. The mar regulon: Multiple resistance to antibiotics and other toxic chemicals. Trends Microbiol. 7, 410-413 (1999).
20. Tsui, W. H. et al. Dual effects of MLS antibiotics: Transcriptional modulation and interactions on the ribosome. Chem. Biol. 11, 1307-1316 (2004).
21. Goh, E. B. et al. Transcriptional modulation of bacterial gene expression by subinhibitory concentrations of antibiotics. Proc. Natl Acad. Sci. USA 99, 17025-17030 (2002).
22. Wright, G. D. Bacterial resistance to antibiotics: Enzymatic degradation and modification. Adv. Drug Deliv. Rev. 57, 1451-1470 (2005).
23. Pootoolal, J., Neu, J. & Wright, G. D. Glycopeptide antibiotic resistance. Annu. Rev. Pharmacol. Toxicol. 42, 381-408 (2002).
24. Walsh, C. T., Fisher, S. L., Park, I.-S., Prohalad, M. & Wu, Z. Bacterial resistance to vancomycin: Five genes and one missing hydrogen bond tell the story. Chem. Biol. 3, 21-28 (1996).
25. Wilson, P. et al. Linezolid resistance in clinical isolates of Staphylococcus aureus. J. Antimicrob. Chemother. 51, 186-188 (2003).
26. Poole, K. Aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 49, 479-487 (2005).
27. D'Costa, V. M., McGrann, K. M., Hughes, D. W. & Wright, G. D. Sampling the antibiotic resistome. Science 311, 374-377 (2006).
28. Piddock, L. J. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin. Microbiol. Rev. 19, 382-402 (2006).
29. Poole, K. & Srikumar, R. Multidrug efflux in Pseudomonas aeruginosa: components, mechanisms and clinical significance. Curr. Top Med. Chem. 1, 59-71 (2001).
30. Stover, C. K. et al. Complete genome sequence of Pseudomonas aeruginosa PAO 1, an opportunistic pathogen. Nature 406, 959-964 (2000).
31. Piddock, L. J. Multidrug-resistance efflux pumps - not just for resistance. Nature Rev. Microbiol. 4, 629-636 (2006).
32. Fisher, J. F., Meroueh, S. O. & Mobashery, S. Bacterial resistance to β-lactam antibiotics: Compelling opportunism, compelling opportunity. Chem. Rev. 105, 395-424 (2005).
33. Sugantino, M. & Roderick, S. L. Crystal structure of Vat(D): An acetyltransferase that inactivates streptogramin group A antibiotics. Biochemistry 41, 2209-2216 (2002).
34. Seoane, A. & Garcia Lobo, J. M. Identification of a streptogramin A acetyltransferase gene in the chromosome of Yersinia enterocolitica. Antimicrob. Agents Chemother. 44, 905-909 (2000).
35. Mukhtar, T. A., Koteva, K. P., Hughes, D. W. & Wright, G. D. Vgb from Staphylococcus aureus inactivates streptogramin B antibiotics by an elimination mechanism not hydrolysis. Biochemistry 40, 8877-8886 (2001).
36. Canton, R. & Coque, T. M. The CTX-M β-lactamase pandemic. Curr. Opin. Microbiol. 9, 466-475 (2006).
37. Humeniuk, C. et al. β-Lactamases of Kluyvera ascorbata, probable progenitors of some plasmid-encoded CTX-M types. Antimicrob. Agents Chemother. 46, 3045-3049 (2002).
38. Poirel, L., Kampfer, P. & Nordmann, P. Chromosome-encoded Ambler class A β-lactamase of Kluyvera georgiana, a probable progenitor of a subgroup of CTX-M extended-spectrum β-lactamases. Antimicrob. Agents Chemother. 46, 4038-4040 (2002).
39. Decousser, J. W., Poirel, L & Nordmann, P. Characterization of a chromosomally encoded extended-spectrum class A β-lactamase from Kluyvera cryocrescens. Antimicrob. Agents Chemother. 45, 3595-3598 (2001).
40. Lartigue, M. F., Poirel, L., Aubert, D. & Nordmann, P. In vitro analysis of ISEcp 1B-mediated mobilization of naturally occurring β-lactamase gene blaCTX-M of Kluyvera ascorbata. Antimicrob. Agents Chemother. 50, 1282-1286 (2006).
41. Wright, G. D., Berghuis, A. M. & Mobashery, S. Aminoglycoside antibiotics. Structures, functions, and resistance. Adv. Exp. Med. Biol. 456, 27-69 (1998).
42. Hachler, H., Santarnam, P. & Kayser, F. H. Sequence and characterization of a novel chromosomal aminoglycoside phosphotransferase gene aph(3′)-llb in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 40, 1254-1256 (1996).
43. Thompson, P. R., Hughes, D. W., Cianciotto, N. P. & Wright, G. D. Spectinomycin kinase from Legionella pneumophila. Characterization of substrate specificity and identification of catalytically important residues. J. Biol. Chem. 273, 14788-14795 (1998).
44. Draker, K. A., Boehr, D. D., Elowe, N. H., Noga, T. J. & Wright, G. D. Functional annotation of putative aminoglycoside antibiotic modifying proteins in Mycobacterium tuberculosis H37Rv. J. Antibiot. (Tokyo) 56, 135-142 (2003).
45. Poirel, L., Decousser, J. W. & Nordmann, P. Insertion sequence ISEcp 1B is involved in expression and mobilization of a bla(CTX-M) β-lactamase gene. Antimicrob. Agents Chemother. 47, 2938-2945 (2003).
46. Toleman, M. A., Bennett, P. M. & Walsh, T. R. ISCR elements: Novel gene-capturing systems of the 21st century? Microbiol. Mol. Biol. Rev. 70, 296-316 (2006).
47. Hall, R. M. & Collis, C. M. Antibiotic resistance in Gram-negative bacteria: The role of gene cassettes and integrons. Drug Resist. Updat. 1, 109-119 (1998).
48. 2-fixing endosymbiont Sinorhizobium meliloti. Proc. Natl Acad. Sci. USA 98, 9889-9894 (2001).
49. Gilmour, M. W., Thomson, N. R., Sanders, M., Parkhill, J. & Taylor, D. E. The complete nucleotide sequence of the resistance plasmid R478: defining the backbone components of incompatibility group H conjugative plasmids through comparative genomics. Plasmid 52, 182-202 (2004).
50. O'Driscoll, J., Glynn, F., Fitzgerald, G. F. & van Sinderen, D. Sequence analysis of the lactococcal plasmid pNP40: A mobile replicon for coping with environmental hazards. J. Bacteriol. 188, 6629-6639 (2006).
51. Baltz, R. H. Antibiotic discovery from actinomycetes: Will a renaissance follow the decline and fall? SIM News 55, 186-196 (2005).
52. Hall, B. G. & Barlow, M. Evolution of the serine β-lactamases: Past, present and future. Drug Resist. Updat. 7. 111-123 (2004).
53. Cundliffe, E. How antibiotic-producing organisms avoid suicide. Annu. Rev. Microbiol. 43, 207-233 (1989).
54. Barna, J. C. & Williams, D. H. The structure and mode of action of glycopeptide antibiotics of the vancomycin group. Annu. Rev. Microbiol. 38, 339-357 (1984).
55. Kirst, H. A., Thompson, D. G. & Nicas, T. I. Historical yearly usage of vancomycin. Antimicrob. Agents Chemother. 42, 1303-1304 (1998).
56. Leclercq, R., Derlot, E., Duval, J. & Courvalin, P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N. Engl. J. Med. 319, 157-161 (1988).
57. Tenover, F. C. et al. Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania. Antimicrob. Agents Chemother. 48, 275-280 (2004).
58. Whitener, C. J. et al. Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure. Clin. Infect Dis. 38, 1049-1055 (2004).
59. Arthur, M. et al. Mechanisms of glycopeptide resistance in enterococci. J. Infect. 32, 11-16 (1996).
60. Courvalin, P. Vancomycin resistance in Gram-positive cocci. Clin. Infect Dis. 42 (Suppl. 1), 25-34 (2006).
61. Bugg, T. D. H. et al. Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: Biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA. Biochemistry 30, 10408-10415 (1991).
62. Marshall, C. G., Broadhead, G., Leskiw, B. K. & Wright, G. D. D-ala-D-ala ligases from glycopeptide antibiotic-producing organisms are highly homologous to the enterococcal vancomycin-resistance ligases VanA and VanB. Proc. Natl Acad. Sci. USA 94, 6480-6483 (1997).
63. Marshall, C. G., Lessard, I. A., Park, I. & Wright, G. D. Glycopeptide antibiotic resistance genes in glycopeptide-producing organisms. Antimicrob. Agents Chemother. 42, 2215-2220 (1998).
64. Marshall, C. G. & Wright, G. D. The glycopeptide antibiotic producer Streptomyces toyocaensis NRRL 15009 has both d-alanyl-d-alanine and d-alanyl-d-lactate ligases. FEMS Microbiol. Lett. 157, 295-299 (1997).
65. Marshall, C. G. & Wright, G. D. DdIN from vancomycin-producing Amycolatopsis orientalis C329.2 is a VanA homologue with d-alanyl-d-lactate ligase activity. J. Bacteriol. 180, 5792-5795 (1998).
66. Marshall, C. G., Zolli, M. & Wright, G. D. Molecular mechanism of VanHst, an α-ketoacid dehydrogenase required for glycopeptide antibiotic resistance from a glycopeptide producing organism. Biochemistry 38, 8485-8491 (1999).
67. Hong, H. J. et al. Characterization of an inducible vancomycin resistance system in Streptomyces coelicolor reveals a novel gene (vank) required for drug resistance. Mol. Microbiol. 52, 1107-1121 (2004).
68. Patel, R., Piper, K., Cockerill, F. R., Steckelberg, J. M. & Yousten, A. A. The biopesticide Paenibacillus popilliae has a vancomycin resistance gene cluster homologous to the enterococcal VanA vancomycin resistance gene cluster. Antimicrob. Agents Chemother. 44, 705-709 (2000).
69. Benveniste, R. & Davies, J. Aminoglycoside antibiotic-inactivating enzymes in actinomycetes similar to those present in clinical isolates of antibiotic-resistant bacteria. Proc. Natl Acad. Sci. USA 70, 2276-2280 (1973).
70. Piepersberg, W. in Biotechnology of industrial antibiotics (ed. Strohl, W.) 81-163 Marcel Dekker, New York, 1997).
71. Boehr, D. D., Thompson, P. R. & Wright, G. D. Molecular mechanism of aminoglycoside antibiotic kinase APH(3′)-IIIa: Roles of conserved active site residues. J. Biol. Chem. 276, 23929-23936 (2001).
72. Daigle, D. M., McKay, G. A., Thompson, P. R. & Wright, G. D. Aminoglycoside phosphotransferases required for antibiotic resistance are also serine protein kinases. Chem. Biol. 6, 11-18 (1998).
73. Daigle, D. M., McKay, G. A. & Wright, G. D. Inhibition of aminoglycoside antibiotic resistance enzymes by protein kinase inhibitors. J. Biol. Chem. 272, 24755-24758 (1997).
74. Hon, W. C. et al. Structure of an enzyme required for aminoglycoside resistance reveals homology to eukaryotic protein kinases. Cell 89, 887-895 (1997).
75. Deutscher, J. & Saier, M. H. Jr. Ser/Thr/Tyr protein phosphorylation in bacteria - for long time neglected. now well established. J. Mol. Microbiol. Biotechnol. 9, 125-131 (2005).
76. Kennelly, P. J. & Potts, M. Fancy meeting you here! a fresh look at 'prokaryotic' protein phosphorylation. J. Bacteriol. 178, 4759-4764 (1996).
77. Bentley, S. D. et al. Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2). Nature, 417, 141-147 (2002).
78. Ikeda, H. et al. Complete genome sequence and comparative analysis of the industrial microorganism Streptomyces overmitilis. Nature Biotechnol. 21, 526-531 (2003).
79. Vetting, M. W., Hegde, S. S., Javid-Majd, F., Blanchard, J. S. & Roderick, S. L. Aminoglycoside 2′-N-acetyltransferase from Mycobacterium tuberculosis in complex with coenzyme A and aminoglycoside substrates. Nature Struct. Biol. 9, 653-658 (2002).
80. Vetting, M. W., Magnet, S., Nieves, E., Roderick, S. L. & Blanchard, J. S. A bacterial acetyltransferase capable of regioselective N-acetylation of antibiotics and histones. Chem. Biol. 11, 565-573 (2004).
81. Wolf, E. et al. Crystal structure of a GCN5-related N-acetyltransferase: Serratia marcescens aminoglycoside 3-N-acetyltransferase. Cell 94, 439-449 (1998).
82. Wybenga-Groot, L., Draker, K. a., Wright, G. D. & Berghuis, A. M. Crystal structure of an aminoglycoside 6′-N-acetyltransferase:dEfining the GCN5-related N-acetyltransferase superfamily fold. Structure 7, 497-507 (1999).
83. Vetting, M. W. et al. Structure and functions of the GNAT superfamily of acetyltransferases. Arch. Biochem. Biophys. 433, 212-226 (2005).
84. Massova, I. & Mobashery, S. Kinship and diversification of bacterial penicillin-binding proteins and β-lactamases. Antimicrob. Agents Chemother. 42, 1-17 (1998).
85. Robicsek, A. et al. Fluoroquinolone-modifying enzyme: A new adaptation of a common aminoglycoside acetyltransferase. Nature Med. 12. 83-88 (2006).
86. Cirz, R. T. et al. Inhibition of mutation and combating the evolution of antibiotic resistance PLoS Biol. 3, e176 (2005).
87. Cirz, R. T., O'Neill B, M., Hammond, J. A., Head, S. R. & Romesberg, F. E. Defining the Pseudomonas aeruginosa SOS response and its role in the global response to the antibiotic ciprofloxacin. J. Bacteriol. 188, 7101-7110 (2006).
88. Heinemann, J. A. How antibiotics cause antibiotic resistance. Drug Discov. Today 4, 72-79 (1999).
89. Morris, R. P. et al. Ancestral antibiotic resistance in Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA 102, 12200-12205 (2005).
90. Walsh, C. T. Polyketide and nonribosomal peptide antibiotics: Modularity and versatility. Science 303, 1805-1810 (2004).
91. Yim, G., Wang, H. H. & Davies, J. The truth about antibiotics. Int. J. Med. Microbiol. 296, 163-170 (2006).
92. Riesenfeld, C. S., Goodman, R. M. & Handelsman, J. Uncultured soil bacteria are a reservoir of new antibiotic resistance genes. Environ. Microbiol. 6, 981-989 (2004).
93. Yeh, P., Tschumi, A. I. & Kishony, R. Functional classification of drugs by properties of their pairwise interactions. Nature Genet. 38, 489-494 (2006).
94. Andersson, D. I. The biological cost of mutational antibiotic resistance: Any practical conclusions? Curr. Opin. Microbiol. 9, 461-465 (2006).
95. Andersson, D. I. Persistence of antibiotic resistant bacteria. Curr. Opin. Microbiol. 6, 452-456 (2003).
96. Handel, A., Regoes, R. R. & Antia, R. The role of compensatory mutations in the emergence of drug resistance. PLoS Comput. Biol. 2, e137 (2006).
97. Kim, C., Cha, J. Y., Yan, H., Vakulenko, S. B. & Mobashery S. Hydrolysis of ATP by aminoglycoside 3′-phosphotransferases: An unexpected cost to bacteria for harboring an antibiotic resistance enzyme. J. Biol. Chem. 281, 6964-6969 (2006).
98. Thompson, J. D., Higgins, D. G. & Gibson, T. J. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22, 4673-4680 (1994).
99. Perrière, G. & Gouy, M. WWW-Query: An on-line retrieval system for biological sequence banks. Biochimie 78, 364-369 (1996).